Intellectual Property India Publishes Patent Application for 'Recombinant Fc Domain - Il2 Variant Polypeptides And Combination Therapy With Membrane-Anchored Antigen Binding Polypeptides' Filed by F. Hoffmann-La Roche Ag

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202547068157 A) filed by F. Hoffmann-La Roche Ag, Basel, Switzerland, on July 17, for 'recombinant fc domain - il2 variant polypeptides and combination therapy with membrane-anchored antigen binding polypeptides.'

Inventor(s) include Darowski, Diana; Gasser, Stephan; Klein, Christian; Lang, Simone; and Venetz, Dario.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to the combination therapy of recombinant Fc domain - IL-2 variant polypeptides with membrane-anchored antigen binding polypeptides in the prevention or treatment of cancer."

The patent application was internationally filed on Jan. 18, 2024, under International application No.PCT/EP2024/051096.

Disclaimer: Curated by HT Syndication.